Literature DB >> 16211552

Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180-1187.

Abraham Zingher, P Mortimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16211552     DOI： 10.1002/rmv.480

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN： 1052-9276            Impact factor:   6.989


× No keyword cloud information.
  19 in total

Review 1.  Convalescent plasma: new evidence for an old therapeutic tool?

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

Review 2.  Attenuated oncolytic measles virus strains as cancer therapeutics.

Authors:  P Msaouel; I D Iankov; A Dispenzieri; E Galanis
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

Review 3.  Oncolytic Virotherapy: A Contest between Apples and Oranges.

Authors:  Stephen J Russell; Kah-Whye Peng
Journal:  Mol Ther       Date:  2017-04-06       Impact factor: 11.454

Review 4.  Measles Resurgence and Drug Development.

Authors:  Richard K Plemper
Journal:  Curr Opin Virol       Date:  2020-04-01       Impact factor: 7.090

Review 5.  Oncolytic measles virus strains as novel anticancer agents.

Authors:  Pavlos Msaouel; Mateusz Opyrchal; Evidio Domingo Musibay; Evanthia Galanis
Journal:  Expert Opin Biol Ther       Date:  2013-01-06       Impact factor: 4.388

Review 6.  Measles virus for cancer therapy.

Authors:  S J Russell; K W Peng
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 7.  Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.

Authors:  Megan K Young; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2013-06-19       Impact factor: 3.452

8.  Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light.

Authors:  Luis Larrea; Emma Castro; Laura Navarro; Belén Vera; Clara Francés-Gómez; Beatriz Sánchez-Sendra; Ángel Giménez; Emilia Castelló; Miriam Collado; María-Jesus Vayá; Vicente Mirabet; Virginia Callao; María-Isabel Ortiz-de-Salazar; Roberto Roig; Ron Geller; Cristina Arbona
Journal:  Blood Transfus       Date:  2021-08-02       Impact factor: 5.752

Review 9.  Incubation periods of acute respiratory viral infections: a systematic review.

Authors:  Justin Lessler; Nicholas G Reich; Ron Brookmeyer; Trish M Perl; Kenrad E Nelson; Derek A T Cummings
Journal:  Lancet Infect Dis       Date:  2009-05       Impact factor: 25.071

10.  Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates.

Authors:  Chad E Mire; Joan B Geisbert; Krystle N Agans; Emily P Thi; Amy C H Lee; Karla A Fenton; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.